BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 17310845)

  • 1. Increased adiponectin level in non-Hodgkin lymphoma and its relationship with interleukin-10. Correlation with clinical features and outcome.
    Pamuk GE; Turgut B; Demir M; Vural O
    J Exp Clin Cancer Res; 2006 Dec; 25(4):537-41. PubMed ID: 17310845
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum and urine levels of interleukin-8 in patients with non-Hodgkin's lymphoma.
    Lee HL; Eom HS; Yun T; Kim HJ; Park WS; Nam BH; Moon-Woo S; Lee DH; Kong SY
    Cytokine; 2008 Jul; 43(1):71-5. PubMed ID: 18502145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of interleukin-10 gene polymorphisms on clinical outcome of patients with aggressive non-Hodgkin's lymphoma: an exploratory study.
    Kube D; Hua TD; von Bonin F; Schoof N; Zeynalova S; Klöss M; Gocht D; Potthoff B; Tzvetkov M; Brockmöller J; Löffler M; Pfreundschuh M; Trümper L
    Clin Cancer Res; 2008 Jun; 14(12):3777-84. PubMed ID: 18559596
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum level of intercellular adhesion molecule-1 in children with malignant lymphoma.
    Abdelrazik N; Fouda M; Zaghloul MH; Abbas D
    Med Princ Pract; 2008; 17(3):233-8. PubMed ID: 18408393
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decreased dickkopf-1 levels in chronic lymphocytic leukemia and increased osteopontin levels in non-Hodgkin's lymphoma at initial diagnosis: Could they be playing roles in pathogenesis?
    Pamuk GE; Uyanik MS; Pamuk ON; Maden M; Tapan U
    Hematology; 2015 Jun; 20(5):267-71. PubMed ID: 25271869
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CA 125 levels in patients with non-Hodgkin lymphoma and other hematologic malignancies.
    Dilek I; Ayakta H; Demir C; Meral C; Ozturk M
    Clin Lab Haematol; 2005 Feb; 27(1):51-5. PubMed ID: 15686508
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Antiphospholipid antibodies: their prevalence, clinical significance and correlation with cytokine levels in acute myeloid leukemia and non-Hodgkin's lymphoma].
    Sciarra A; Stasi R; Stipa E; Masi M; Oliva F; Olivieri M; Perrotti A; Zaccari G; Amadori S; Papa G
    Recenti Prog Med; 1995 Feb; 86(2):57-62. PubMed ID: 7754173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiphospholipid antibodies: prevalence, clinical significance and correlation to cytokine levels in acute myeloid leukemia and non-Hodgkin's lymphoma.
    Stasi R; Stipa E; Masi M; Oliva F; Sciarra A; Perrotti A; Zaccari G; Papa G
    Thromb Haemost; 1993 Oct; 70(4):568-72. PubMed ID: 8115979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum thymidine kinase in non-Hodgkin lymphomas with special regard to multiple myeloma.
    Poley S; Stieber P; Nüssler V; Pahl H; Fateh-Moghadam A
    Anticancer Res; 1997; 17(4B):3025-9. PubMed ID: 9329592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin-10 gene polymorphisms influence the clinical course of non-Hodgkin's lymphoma.
    Bogunia-Kubik K; Mazur G; Wróbel T; Kuliczkowski K; Lange A
    Tissue Antigens; 2008 Feb; 71(2):146-50. PubMed ID: 18201362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Plasma interleukin-6 and interleukin-10 levels in different subtypes of lymphoma and their clinical significance].
    Wang X; Zhao HR; Gu X; Liu P; Bikmituofu H
    Nan Fang Yi Ke Da Xue Xue Bao; 2011 Aug; 31(8):1360-4. PubMed ID: 21868324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma polychlorobiphenyl and organochlorine pesticide level and risk of major lymphoma subtypes.
    Cocco P; Brennan P; Ibba A; de Sanjosé Llongueras S; Maynadié M; Nieters A; Becker N; Ennas MG; Tocco MG; Boffetta P
    Occup Environ Med; 2008 Feb; 65(2):132-40. PubMed ID: 17699548
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adiponectin, IL-10 and metabolic syndrome in obese children and adolescents.
    Calcaterra V; De Amici M; Klersy C; Torre C; Brizzi V; Scaglia F; Albanesi M; Albertini R; Allais B; Larizza D
    Acta Biomed; 2009 Aug; 80(2):117-23. PubMed ID: 19848048
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation of serum IL-6, IL-8 and IL-10 levels with clinicopathological features and prognosis in patients with diffuse large B-cell lymphoma.
    Nacinović-Duletić A; Stifter S; Dvornik S; Skunca Z; Jonjić N
    Int J Lab Hematol; 2008 Jun; 30(3):230-9. PubMed ID: 18479302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Abnormal fatty acid distribution of the serum phospholipids of patients with non-Hodgkin lymphoma.
    Cvetković Z; Vucić V; Cvetković B; Petrović M; Ristić-Medić D; Tepsić J; Glibetić M
    Ann Hematol; 2010 Aug; 89(8):775-82. PubMed ID: 20127484
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin-10 gene polymorphism influences the prognosis of T-cell non-Hodgkin lymphomas.
    Lee JJ; Kim DH; Lee NY; Sohn SK; Kim JG; Kim HJ; Do YR; Park YH
    Br J Haematol; 2007 May; 137(4):329-36. PubMed ID: 17408400
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical features and outcome of Chinese patients with monoclonal B-cell lymphocytosis.
    Xu W; Li JY; Wu YJ; Cao X; Fan L; Qiao C; Liu Q; Yao L; Miao KR
    Leuk Res; 2009 Dec; 33(12):1619-22. PubMed ID: 19250675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Limited usefulness of CA125 measurement in the management of Hodgkin's and non-Hodgkin's lymphoma.
    Bonnet C; Beguin Y; Fassotte MF; Seidel L; Luyckx F; Fillet G
    Eur J Haematol; 2007 May; 78(5):399-404. PubMed ID: 17419741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence, clinical pattern, and outcome of CNS involvement in childhood and adolescent non-Hodgkin's lymphoma differ by non-Hodgkin's lymphoma subtype: a Berlin-Frankfurt-Munster Group Report.
    Salzburg J; Burkhardt B; Zimmermann M; Wachowski O; Woessmann W; Oschlies I; Klapper W; Wacker HH; Ludwig WD; Niggli F; Mann G; Gadner H; Riehm H; Schrappe M; Reiter A
    J Clin Oncol; 2007 Sep; 25(25):3915-22. PubMed ID: 17761975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical and laboratory prognostic parameters for leukemic types of chronic lymphoproliferative diseases].
    Kardum-Skelin I; Planinc-Peraica A; Ostojić Kolonić S; Radić-Kristo D; Milas M; Vrhovac R; Sustercić D; Minigo H; Jaksić B
    Acta Med Croatica; 2008 Oct; 62(4):351-64. PubMed ID: 19205412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.